aspirin and lamifiban

aspirin has been researched along with lamifiban in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (50.00)	18.2507
2000's	4 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Carteaux, JP; Clozel, JP; Falivene, L; Hess, P; Roux, S	1
Rossi, G	1
Kaluza, G; Kleiman, NS; Mazur, W	1
Clemetson, JM; Clemetson, KJ; Dörmann, D; Navdaev, A	1
Bode, C; Nordt, TK; Peter, K	1

Reviews

2 review(s) available for aspirin and lamifiban

Article	Year
Antiplatelet therapy for treatment of acute coronary syndromes. Cardiology clinics, 1999, Volume: 17, Issue:2 Topics: Abciximab; Acetates; Antibodies, Monoclonal; Aspirin; Clopidogrel; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine; Vascular Patency	1999
[GPIIb/IIIa blockers for optimizing thrombolysis in acute myocardial infarct]. Herz, 2001, Volume: 26 Suppl 1 Topics: Abciximab; Acetates; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Plasminogen Activators; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Tyrosine	2001

Article

Year

Antiplatelet therapy for treatment of acute coronary syndromes.

Cardiology clinics, 1999, Volume: 17, Issue:2

Topics: Abciximab; Acetates; Antibodies, Monoclonal; Aspirin; Clopidogrel; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine; Vascular Patency

1999

[GPIIb/IIIa blockers for optimizing thrombolysis in acute myocardial infarct].

Herz, 2001, Volume: 26 Suppl 1

Topics: Abciximab; Acetates; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Plasminogen Activators; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Tyrosine

2001

Trials

1 trial(s) available for aspirin and lamifiban

Article	Year
International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. The PARAGON Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Gl Circulation, 1998, Jun-23, Volume: 97, Issue:24 Topics: Acetates; Aged; Angina, Unstable; Anticoagulants; Aspirin; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Survival Analysis; Tyrosine	1998

Article

Year

International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. The PARAGON Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndrome events in a Gl

Circulation, 1998, Jun-23, Volume: 97, Issue:24

Topics: Acetates; Aged; Angina, Unstable; Anticoagulants; Aspirin; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Survival Analysis; Tyrosine

1998

Other Studies

5 other study(ies) available for aspirin and lamifiban

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Experimental carotid thrombosis in the guinea pig. Thrombosis and haemostasis, 1994, Volume: 71, Issue:2 Topics: Acetates; Animals; Aspirin; Biomechanical Phenomena; Blood Flow Velocity; Blood Pressure; Carotid Artery Thrombosis; Disease Models, Animal; Guinea Pigs; Heparin; Hirudin Therapy; Male; Partial Thromboplastin Time; Platelet Aggregation; Platelet Count; Tyrosine	1994
[Superaspirin in the platelet aggregation inhibitor therapy]. Recenti progressi in medicina, 1997, Volume: 88, Issue:12 Topics: Abciximab; Acetates; Antibodies, Monoclonal; Aspirin; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Integrins; Myocardial Infarction; Oligopeptides; Peptides, Cyclic; Platelet Aggregation Inhibitors; Recurrence; Sulfoxides; Thiazolidines; Time Factors; Tyrosine	1997
[New antiplatelet agents]. Investigacion clinica, 2000, Volume: 41, Issue:3 Topics: Abciximab; Acetates; Antibodies, Monoclonal; Anticoagulants; Aspirin; Clopidogrel; Cyclooxygenase Inhibitors; Dipyridamole; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Ticlopidine; Tirofiban; Tyrosine	2000
Echicetin, a GPIb-binding snake C-type lectin from Echis carinatus, also contains a binding site for IgMkappa responsible for platelet agglutination in plasma and inducing signal transduction. Blood, 2001, Apr-15, Volume: 97, Issue:8 Topics: Acetates; Animals; Aspirin; Avidin; Binding Sites; Biotinylation; Blood Proteins; Carrier Proteins; Chelating Agents; Edetic Acid; Fibrinogen; Immunoglobulin kappa-Chains; Immunoglobulin M; Lectins; Macromolecular Substances; P-Selectin; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Proteins; Signal Transduction; Tyrosine; Viper Venoms	2001